Li Ang, Li Linhui, Zhao Bin'an, Li Xiaotong, Liang Wencheng, Lang Meidong, Cheng Biao, Li Jun
Department of Orthopedics, Shanghai Tenth People's Hospital affiliated to Tongji University, 301 Yanchang Road, Shanghai 200072, China; Department of General Surgery, The Affiliated Shanghai Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, 528 Zhangheng Road, Shanghai 201203, China.
Department of Burns, The First Affiliated Hospital of Naval Medical University, No. 168 ChanghaiRoad, Yangpu District, Shanghai 200433, China.
Int J Biol Macromol. 2022 Jan 1;194:914-923. doi: 10.1016/j.ijbiomac.2021.11.146. Epub 2021 Nov 25.
Epigallocatechin-3-O-gallate (EGCG) is a green biomedical agent for promoting wound healing, which possess excellent antibacterial, antioxidant and anti-inflammatory activities. For improving the low bioavailability challenges of EGCG in vivo, we had successful created a low-cost and simple wound dressing Poly (L-Lactic-co-caprolactone) (PLCL)/Gelatin/EGCG/Core-shell nanofiber membrane (PGEC) with drug sustained release capacity through coaxial electrospinning technology. In vitro experimental indicated that the core-shell structure wound dressing had excellent biocompatibility, antibacterial and antioxidant ability, which could support cell viability and proliferation, encourage re-epithelialization during the healing process, inhibit subsequent wound infection and thus promote wound regeneration. In vivo experimental demonstrated that PGEC wound dressing could promote wound healing, the histological results further demonstrated that PGEC not only facilitated early wound closure but also influenced cellular differentiation and tissue organization. Meanwhile, PGEC had excellent hemostatic ability. Taken all together, we believed that the PGEC wound dressing, which could localize delivery of EGCG, had high potential clinical application for promoting wound healing, hemostasis or other related clinical applications in the future.
表没食子儿茶素-3-没食子酸酯(EGCG)是一种促进伤口愈合的绿色生物医学制剂,具有出色的抗菌、抗氧化和抗炎活性。为改善EGCG在体内生物利用度低的问题,我们通过同轴静电纺丝技术成功制备了一种具有药物缓释能力的低成本且简单的伤口敷料聚(L-乳酸-共-己内酯)(PLCL)/明胶/EGCG/核壳纳米纤维膜(PGEC)。体外实验表明,核壳结构的伤口敷料具有优异的生物相容性、抗菌和抗氧化能力,能够支持细胞活力和增殖,在愈合过程中促进上皮再形成,抑制后续伤口感染,从而促进伤口再生。体内实验证明,PGEC伤口敷料可促进伤口愈合,组织学结果进一步表明,PGEC不仅有助于早期伤口闭合,还影响细胞分化和组织形成。同时,PGEC具有出色的止血能力。综上所述,我们认为能够局部递送EGCG的PGEC伤口敷料在未来促进伤口愈合、止血或其他相关临床应用方面具有很高的临床应用潜力。